Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03902171Unknown

Soberlink Within In-Home Addiction Treatment Program

Role: collaborator

NCT03190356Terminated

Soberlink - MAP Outcomes Study Protocol

Role: lead

NCT02794038Not ApplicableCompleted

Accuracy & Usability Study for Soberlink Cellular Device

Role: lead

NCT02650180Not ApplicableCompleted

Usability Study for SOBERLINK System

Role: lead

All 4 trials loaded